Search

Search Constraints

You searched for: Author/Creator Hackney, Jason A.

Search Results

1. Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial. Issue 10 (24th August 2021)

2. Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial. Issue 9 (28th August 2020)

3. Obligate role for Rock1 and Rock2 in adult stem cell viability and function. Issue 3 (March 2023)